Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.

Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.

Item
http://www.wikidata.org/entity/Q34648896
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisCurrent approaches to the management of new-onset ulcerative colitis.Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates.Conventional drug therapy for inflammatory bowel disease.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?Optimizing pharmacologic management of inflammatory bowel disease.Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis.Relationship between the pH of enema solutions and intestinal damage in rabbits.Letter: assessment of safety and efficacy of mesalazine in Indian patients with ulcerative colitis.Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial.Electronic Monitoring of Medication Adherence in a 1-year Clinical Study of 2 Dosing Regimens of Mesalazine for Adults in Remission with Ulcerative Colitis
P2860

Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.

Item
http://www.wikidata.org/entity/Q34648896
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Randomised clinical trial: onc ...... for active ulcerative colitis.
@ast
Randomised clinical trial: onc ...... for active ulcerative colitis.
@en
Randomised clinical trial: onc ...... for active ulcerative colitis.
@nl
type
label
Randomised clinical trial: onc ...... for active ulcerative colitis.
@ast
Randomised clinical trial: onc ...... for active ulcerative colitis.
@en
Randomised clinical trial: onc ...... for active ulcerative colitis.
@nl
prefLabel
Randomised clinical trial: onc ...... for active ulcerative colitis.
@ast
Randomised clinical trial: onc ...... for active ulcerative colitis.
@en
Randomised clinical trial: onc ...... for active ulcerative colitis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Randomised clinical trial: onc ...... for active ulcerative colitis
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698